サンプル依頼リスト カート
  • English
市場調査レポート
商品コード
1206501

中東・アフリカのECMO市場の2028年までの予測- 地域別分析- モダリティ別、用途別、年齢層別

Middle East & Africa ECMO Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Modality, Application, and Age Group
出版日: | 発行: The Insight Partners | ページ情報: 英文 120 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
中東・アフリカのECMO市場の2028年までの予測- 地域別分析- モダリティ別、用途別、年齢層別
出版日: 2023年01月24日
発行: The Insight Partners
ページ情報: 英文 120 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

中東・アフリカのECMO市場は、2022年の2,974万米ドルから2028年には3,354万米ドルに成長すると予測されています。2022年から2028年までのCAGRは2.0%で成長すると推定されます。

肺移植術におけるECMOの採用拡大が中東・アフリカのECMO市場の成長を促進する

肺移植は、COPD、特発性肺線維症（IPF）、嚢胞性線維症などの末期肺疾患を患う患者にとって、生活の質を向上させるための救命処置の選択肢です。ECMOは、術前、術中、術後など、肺移植のすべてのフェーズで使用される汎用性の高いツールです。ECMOは、肺移植を受ける患者さんの橋渡し役として機能します。そのため、生命を脅かす肺疾患の患者を管理するために、肺移植時のECMOの採用は急速に拡大しています。原発性移植片機能不全（PGD）は、肺移植後の死亡の主な原因です。ECMOは、肺移植後のPGDの治療に優先的に使用されます。したがって、ECMO装置の需要は、PGDに苦しむ患者を治療するために高まっています。

中東・アフリカのECMO市場の概要

中東・アフリカのECMO市場は、UAE、サウジアラビア、南アフリカ、Rest of 中東・アフリカに区分されます。南アフリカは、予測期間中、中東・アフリカのECMO市場において最大の市場シェアを占めています。南アフリカは、高血圧や心停止などの慢性心血管系疾患の負担に直面しています。同国では、冠状動脈性心疾患（CHD）や脳卒中などの心血管疾患の負担が増加しています。WHOによると、南アフリカの成人のCVDによる早死率は、2000年から2030年の間に41%増加すると予測されています。さらに、南アフリカでは、脳卒中は死亡と障害の主要な原因となっています。人口の高齢化とともに、脳卒中の危険因子への曝露や発症が増加し、疫学的な移行が急速に進んでいるため、脳卒中の負担は今後数年間で増加すると予想されます。南アフリカのヘルスケア施設は、より良い治療と診断を提供するために、最新の技術を開発し採用しています。この地域は依然として政治的な不確実性に大きくさらされていますが、医療機器の輸出は、商品価格の上昇と投資家の意欲の向上に後押しされたサハラ以南のアフリカの経済成長の加速から得られるでしょう。サハラ以南のアフリカでは、南アフリカが医療機器産業の重要なビジネスセンターとなっています。医療機器・検査機器の輸出は、アフリカ諸国への輸出が多く、輸出先上位20カ国のうち12カ国がアフリカ諸国となっています。したがって、上記の要因から、予測期間中、南アフリカのECMO市場成長にとって好都合なシナリオを提供することが期待されます。

中東・アフリカのECMO市場の収益と2028年までの予測

中東・アフリカのECMO市場のセグメント化

中東・アフリカのECMO市場は、モダリティ別、用途別、年齢層別、国別に基づいてセグメント化されています。

モダリティに基づき、中東・アフリカのECMO市場は静脈動脈性ECMO、静脈性ECMO、動静脈性ECMOに区分されます。2022年には、静脈動脈ECMOセグメントが最大の市場シェアを占めました。

用途に基づき、中東・アフリカのECMO市場は呼吸器と心臓病学に二分されます。2022年には呼吸器分野がより大きな市場シェアを占めました。

年齢層に基づき、中東・アフリカのECMO市場は成人、小児科、新生児に区分されます。2022年には成人セグメントが最も大きな市場シェアを占めました。

国別に見ると、中東・アフリカのECMO市場は、UAE、サウジアラビア、南アフリカ、Rest of 中東・アフリカに分類されます。地域別分析では、2022年に南アフリカが市場を独占しています。

ABIOMED Inc、Braile Biomedica、Fresenius Medical Care AG &Co KGaA、Getinge AB、LivaNova Plc、Medtronic Plc、MicroPort Scientific Corporation、Nipro Medical Corporation、Terumo Groupは中東・アフリカのECMO市場で事業を展開している主要企業です。

目次

第1章 イントロダクション

第2章 重要なポイント

第3章 調査手法

  • カバレッジ
  • 2次調査
  • 1次調査

第4章 中東・アフリカのECMO市場- 市場情勢

  • 中東・アフリカのPEST分析
  • 専門家の見解

第5章 中東・アフリカのECMO市場- 主要市場力学

  • 市場促進要因
    • 心血管疾患と呼吸不全の有病率の上昇
    • 肺移植術におけるECMOの採用拡大
  • 市場抑制要因
    • ECMOに関連する合併症
  • 市場機会
    • ECMO別生存率の向上
  • 今後の動向
    • 製品開発および承認の急増
  • 影響分析

第6章 ECMO市場-中東・アフリカ分析

  • 中東・アフリカのECMO市場収益と予測・分析

第7章 中東・アフリカのECMO市場分析中東・アフリカのECMO市場の分析- モダリティ別

  • 中東・アフリカのECMO市場のモダリティ別、シェア 2021年・2028年（%）
  • 静脈内ECMO
  • 動静脈性ECMO
  • 動静脈ECMO

第8章 中東・アフリカのECMOの市場分析- 用途別

  • 中東・アフリカのECMO市場、用途別、2021年・2028年（%）
  • 呼吸器
  • 循環器内科

第9章 中東・アフリカのECMOの市場分析- 年齢層別

  • 中東・アフリカのECMO市場の年齢層別推移：2021年・2028年（%）
  • 成人
  • 小児科
  • 新生児

第10章 中東・アフリカのECMO市場- 国別分析

  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • UAE
    • 中東・アフリカの残りの地域

第11章 業界情勢

  • 無機的成長戦略
  • 有機的成長戦略

第12章 企業プロファイル

  • Terumo Group
  • Medtronic Plc
  • MicroPort Scientific Corporation
  • LivaNova Plc
  • Nipro Medical Corporation
  • Getinge AB
  • Braile Biomedica
  • Fresenius Medical Care AG & Co KGaA
  • ABIOMED Inc

第13章 付録

図表

List Of Tables

  • Table 1. MEA ECMO Market - Revenue and Forecast to 2028 (US$ Million)
  • Table 2. South Africa ECMO Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 3. South Africa ECMO Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 4. South Africa ECMO Market, by Age Group- Revenue and Forecast to 2028 (US$ Million)
  • Table 5. Saudi Arabia ECMO Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 6. Saudi Arabia ECMO Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 7. Saudi Arabia ECMO Market, by Age Group- Revenue and Forecast to 2028 (US$ Million)
  • Table 8. UAE ECMO Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 9. UAE ECMO Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 10. UAE ECMO Market, by Age Group- Revenue and Forecast to 2028 (US$ Million)
  • Table 11. Rest of MEA ECMO Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 12. Rest of MEA ECMO Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 13. Rest of MEA ECMO Market, by Age Group- Revenue and Forecast to 2028 (US$ Million)
  • Table 14. Recent Inorganic Growth Strategies
  • Table 15. Recent Organic Growth Strategies
  • Table 16. Glossary of Terms

List Of Figures

  • Figure 1. MEA ECMO Market Segmentation
  • Figure 2. MEA ECMO Market, By Country
  • Figure 3. MEA ECMO Market Overview
  • Figure 4. MEA ECMO Market, By Modality
  • Figure 5. MEA ECMO Market, By Country
  • Figure 7. MEA: PEST Analysis
  • Figure 8. Experts Opinion
  • Figure 9. Impact Analysis: MEA ECMO Market
  • Figure 10. MEA ECMO Market - Revenue Forecast and Analysis
  • Figure 11. MEA ECMO Market Share by Modality 2021 & 2028 (%)
  • Figure 12. Venoarterial ECMO: MEA ECMO Market Revenue and Forecast To 2028 (US$ Million)
  • Figure 13. Venovenous ECMO: MEA ECMO Market Revenue and Forecast To 2028 (US$ Million)
  • Figure 14. Arteriovenous ECMO: MEA ECMO Market Revenue and Forecast To 2028 (US$ Million)
  • Figure 15. MEA ECMO Market, by Application 2021 & 2028 (%)
  • Figure 16. Respiratory : MEA ECMO Market Revenue and Forecasts To 2028 (US$ MN)
  • Figure 17. Cardiology : MEA ECMO Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 18. MEA ECMO Market, by Age Group 2021 & 2028 (%)
  • Figure 19. Adults : MEA ECMO Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 20. Pediatrics : MEA ECMO Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 21. Neonates : MEA ECMO Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 22. MEA: ECMO Market, by Key Country - Revenue (2021) (US$ Million)
  • Figure 23. MEA: ECMO Market, by Country, 2021& 2028 (%)
  • Figure 24. South Africa: ECMO Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 25. Saudi Arabia: ECMO Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 26. UAE: ECMO Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 27. Rest of MEA: ECMO Market- Revenue and Forecast to 2028 (US$ Million)
目次
Product Code: BMIRE00027934

The MEA ECMO market is expected to grow from US$ 29.74 million in 2022 to US$ 33.54 million by 2028. It is estimated to record a CAGR of 2.0% from 2022 to 2028.

Growing Adoption of ECMO in Lung Transplantation Procedures Drives MEA ECMO Market Growth

Lung transplantation is a life-saving treatment option for patients suffering from end-stage lung diseases, such as COPD, Idiopathic pulmonary fibrosis (IPF), and cystic fibrosis, to improve the quality of life. ECMO is a versatile tool used in all lung transplantation phases, such as preoperative, intraoperative, and postoperative periods. It acts as a bridge for a patient undergoing lung transplantation. Therefore, the adoption of ECMO during lung transplantation is growing rapidly to manage patients with life-threatening lung diseases. Primary graft dysfunction (PGD) is the leading cause of death after a lung transplant. ECMO is used penultimately in treating PGD post lung transplantation. Thus, the demand for ECMO equipment is growing for treating patients suffering from PGD.

MEA ECMO Market Overview

The MEA ECMO Market is segmented into the UAE, Saudi Arabia, South Africa, and the Rest of MEA. South Africa holds the largest market share in the MEA ECMO market during forecast period. South Africa faces a burden of chronic cardiovascular diseases, including high hypertension and cardiac arrest. The country is experiencing an increasing burden of cardiovascular diseases, including coronary heart disease (CHD) and stroke. According to WHO, it is estimated that the rate of premature death due to CVD amongst South African adults is projected to increase by 41% between 2000 and 2030. Moreover, in South Africa, stroke is a leading cause of death and disability. The burden of stroke is expected to increase in the coming years as the population is experiencing a rapid epidemiological transition with increased exposure to and development of stroke risk factors, together with the aging of the population. Healthcare facilities in South Africa are developing and adopting the latest technologies to offer better treatments and diagnoses. Although the region remains highly exposed to political uncertainty, medical device exports will gain from accelerated economic growth in Sub-Saharan Africa, which will be aided by increased commodity prices and improved investor enthusiasm. In Sub-Saharan Africa, South Africa is the key business center for the medical device industry. A large percentage of medical device and lab equipment exports go to other African countries, with 12 African countries among the top 20 export destinations. Thus, owing to the above-mentioned factors, the country is expected to provide an opportunistic scenario for the ECMO market growth in South Africa during the forecast period.

MEA ECMO Market Revenue and Forecast to 2028 (US$ Million)

MEA ECMO Market Segmentation

The MEA ECMO market is segmented based on modality, application, age group, and country.

Based on modality, the MEA ECMO market is segmented into venoarterial ECMO, venovenous ECMO, and arteriovenous ECMO. The venoarterial ECMO segment held the largest market share in 2022.

Based on application, the MEA ECMO market is bifurcated into respiratory and cardiology. The respiratory segment held a larger market share in 2022.

Based on age group, the MEA ECMO market is segmented into adults, pediatrics, and neonates. The adults segment held the largest market share in 2022.

Based on country, the MEA ECMO market has been categorized into the UAE, Saudi Arabia, South Africa, and the Rest of MEA. Our regional analysis states that South Africa dominated the market in 2022.

ABIOMED Inc, Braile Biomedica, Fresenius Medical Care AG & Co KGaA, Getinge AB, LivaNova Plc, Medtronic Plc, MicroPort Scientific Corporation, Nipro Medical Corporation, and Terumo Group are the leading companies operating in the MEA ECMO market.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the MEA ECMO market.
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the MEA ECMO market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth MEA market trends and outlook coupled with the factors driving the ECMO market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 MEA ECMO Market - By Modality
    • 1.3.2 MEA ECMO Market - By Application
    • 1.3.3 MEA ECMO Market - By Age Group
    • 1.3.4 MEA ECMO Market - By Country

2. Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. MEA ECMO Market - Market Landscape

  • 4.1 Overview
  • 4.2 MEA PEST Analysis
  • 4.3 Experts Opinion

5. MEA ECMO Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Rising Prevalence of Cardiovascular Diseases and Respiratory Failures
    • 5.1.2 Growing Adoption of ECMO in Lung Transplantation Procedures
  • 5.2 Market Restraints
    • 5.2.1 Complications Associated with ECMO
  • 5.3 Market Opportunities
    • 5.3.1 Increasing Survival Rates with ECMO
  • 5.4 Future Trends
    • 5.4.1 Surging Product Developments and Approvals
  • 5.5 Impact Analysis

6. ECMO Market - MEA Analysis

  • 6.1 MEA ECMO Market Revenue Forecast & Analysis

7. MEA ECMO Market Analysis - By Modality

  • 7.1 Overview
  • 7.2 MEA ECMO Market Share by Modality 2021 & 2028 (%)
  • 7.3 Venoarterial ECMO
    • 7.3.1 Overview
    • 7.3.2 Venoarterial ECMO: ECMO Market Revenue and Forecast to 2028 (US$ Million)
  • 7.4 Venovenous ECMO
    • 7.4.1 Overview
    • 7.4.2 Venovenous ECMO: ECMO Market Revenue and Forecast to 2028 (US$ Million)
  • 7.5 Arteriovenous ECMO
    • 7.5.1 Overview
    • 7.5.2 Arteriovenous ECMO: ECMO Market Revenue and Forecast to 2028 (US$ Million)

8. MEA ECMO Market Analysis - By Application

  • 8.1 Overview
  • 8.2 MEA ECMO Market, By Application 2021 & 2028 (%)
  • 8.4 Respiratory
    • 8.4.1 Overview
    • 8.4.2 Respiratory Market Revenue and Forecast to 2028 (US$ Mn)
  • 8.5 Cardiology
    • 8.5.1 Overview
    • 8.5.2 Cardiology Market Revenue and Forecast to 2028 (US$ Mn)

9. MEA ECMO Market Analysis - By Age Group

  • 9.1 Overview
  • 9.2 MEA ECMO Market, By Age Group 2021 & 2028 (%)
  • 9.3 Adults
    • 9.3.1 Overview
    • 9.3.2 Adults Market Revenue and Forecast to 2028 (US$ Mn)
  • 9.4 Pediatrics
    • 9.4.1 Overview
    • 9.4.2 Pediatrics Market Revenue and Forecast to 2028 (US$ Mn)
  • 9.5 Neonates
    • 9.5.1 Overview
    • 9.5.2 Neonates Market Revenue and Forecast to 2028 (US$ Mn)

10. MEA ECMO Market - Country Analysis

  • 10.1 Overview
    • 10.1.1 MEA: ECMO Market, by Country, 2021& 2028 (%)
      • 10.1.1.1 South Africa: ECMO Market- Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.1.1 Overview
        • 10.1.1.1.2 South Africa: ECMO Market- Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.1.3 South Africa: ECMO Market, by Modality, 2019-2028 (US$ Million)
        • 10.1.1.1.4 South Africa: ECMO Market, by Application, 2019-2028 (US$ Million)
        • 10.1.1.1.5 South Africa: ECMO Market, by Age Group, 2019-2028 (US$ Million)
      • 10.1.1.2 Saudi Arabia: ECMO Market- Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.2.1 Overview
        • 10.1.1.2.2 Saudi Arabia: ECMO Market- Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.2.3 Saudi Arabia: ECMO Market, by Modality, 2019-2028 (US$ Million)
        • 10.1.1.2.4 Saudi Arabia: ECMO Market, by Application, 2019-2028 (US$ Million)
        • 10.1.1.2.5 Saudi Arabia: ECMO Market, by Age Group, 2019-2028 (US$ Million)
      • 10.1.1.3 UAE: ECMO Market- Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.3.1 Overview
        • 10.1.1.3.2 UAE: ECMO Market- Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.3.3 UAE: ECMO Market, by Modality, 2019-2028 (US$ Million)
        • 10.1.1.3.4 UAE: ECMO Market, by Application, 2019-2028 (US$ Million)
        • 10.1.1.3.5 UAE: ECMO Market, by Age Group, 2019-2028 (US$ Million)
      • 10.1.1.4 Rest of MEA: ECMO Market- Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.4.1 Overview
        • 10.1.1.4.2 Rest of MEA: ECMO Market- Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.4.3 Rest of MEA: ECMO Market, by Modality, 2019-2028 (US$ Million)
        • 10.1.1.4.4 Rest of MEA: ECMO Market, by Application, 2019-2028 (US$ Million)
        • 10.1.1.4.5 Rest of MEA: ECMO Market, by Age Group, 2019-2028 (US$ Million)

11. Industry Landscape

  • 11.1 Overview
  • 11.2 Inorganic Growth Strategies
    • 11.2.1 Overview
  • 11.3 Organic Growth Strategies
    • 11.3.1 Overview

12. Company Profiles

  • 12.1 Terumo Group
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Medtronic Plc
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 MicroPort Scientific Corporation
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 LivaNova Plc
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Nipro Medical Corporation
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Getinge AB
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Braile Biomedica
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Fresenius Medical Care AG & Co KGaA
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 ABIOMED Inc
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments

13. Appendix

  • 13.1 About The Insight Partners
  • 13.2 Glossary of Terms